Journal ArticleLiver Transpl · November 6, 2025
In 2019, the United Network for Organ Sharing (UNOS) policy for patients with hilar cholangiocarcinoma (hCCA) changed from granting a Model for End-Stage Liver Disease (MELD) exception score of 22 with 10% escalation every 3 months to a median MELD at tran ...
Full textLink to itemCite
Journal ArticleClin Transplant · July 2025
Transplantation is one of the few life-saving therapies for patients with end-stage organ disease, yet organ availability remains restrictive. Expanding donors to include those with hepatitis B virus (HBV) infection, incorporating HBV nucleic acid amplific ...
Full textLink to itemCite
Journal ArticleLiver Transpl · June 1, 2025
Normothermic machine perfusion (NMP) facilitates the utilization of marginal liver allografts. It remains unknown whether clinical benefits offset additional costs in the real-world setting. We performed a comparison of outcomes and hospitalization costs f ...
Full textLink to itemCite
Journal ArticleCA Cancer J Clin · 2025
Hepatocellular carcinoma (HCC) is the sixth most common malignancy and the third leading cause of cancer-related death worldwide. Contemporary advances in systemic and locoregional therapies have led to changes in peer-reviewed guidelines regarding systemi ...
Full textLink to itemCite
Journal ArticleTransplant Direct · November 2023
BACKGROUND: Hepatitis C virus (HCV) nucleic acid amplification test (NAAT)-positive donors have increased the organ pool. Direct-acting antivirals (DAAs) have led to high rates of treatment success and sustained virologic response (SVR) in recipients with ...
Full textLink to itemCite
Journal ArticleAm J Transplant · August 2023
Livers from donors with positive hepatitis B surface antigens (HBsAg+) have been used to expand the donor pool; however, outcome data are limited. We aim to evaluate survival following liver transplant (LT) from HBsAg+ donors. Using the United Network for ...
Full textLink to itemCite
ConferenceDig Dis Sci · November 2022
BACKGROUND: Liver Imaging Reporting and Data System (LI-RADS) classifies liver nodules from LR-1 to LR-5 based on risk for hepatocellular carcinoma (HCC). It is challenging to know the nature of the LR-3 and LR-4 lesions. AIMS: To test our hypothesis that ...
Full textLink to itemCite
Journal ArticleHPB (Oxford) · December 2021
BACKGROUND: Liver transplantation is definitive therapy for end stage liver disease in pediatric patients. Living donor liver transplantation (LDLT) with the left lateral segment (LLS) is often a feasible option. However, the size of LLS is an important fa ...
Full textLink to itemCite
Journal ArticleLiver Transpl · August 2021
Historically in the United States, kidneys for simultaneous liver-kidney transplantation (SLKT) candidates were allocated with livers, prioritizing SLKT recipients over much of the kidney waiting list. A 2017 change in policy delineated renal function crit ...
Full textLink to itemCite
Journal ArticleExp Clin Transplant · February 2021
OBJECTIVES: Available data have suggested that directacting antivirals for hepatitis C virus may decrease calcineurin inhibitor concentrations. In this study, our aim was to determine the effects of hepatitis C directacting antivirals on calcineurin inhibi ...
Full textLink to itemCite
Journal ArticleTransplant Direct · January 2021
BACKGROUND: Midodrine is often needed pretransplant to improve hemodynamics in simultaneous liver-kidney transplant candidates. Previous research has shown that patients requiring midodrine before kidney transplant alone have increased posttransplant risk ...
Full textLink to itemCite
Journal ArticleCase Rep Transplant · 2021
Immune thrombocytopenia is a consumptive coagulopathy that can be either idiopathic or associated with infectious or autoimmune etiologies. Here, we present a case of immune thrombocytopenia in the setting of acute liver failure due to coexisting diagnoses ...
Full textLink to itemCite
Journal ArticleWorld J Surg · October 2020
BACKGROUND: Textbook outcome (TO) is an emerging concept within multiple surgical domains, which represents a novel effort to define a standardized, composite quality benchmark based on multiple postoperative endpoints that represent the ideal "textbook" h ...
Full textLink to itemCite
Journal ArticleTransplantation · June 2020
BACKGROUND: Patients with nonalcoholic steatohepatitis (NASH) are waitlisted at older ages than individuals with other liver diseases, but the effect of age on liver transplantation (LT) outcomes in this population and whether it differs from other etiolog ...
Full textLink to itemCite
Journal ArticleGut · June 2019
OBJECTIVE: Uncertainty about acute liver failure (ALF) pathogenesis limits therapy. We postulate that ALF results from excessive reactivation of a fetal liver programme that is induced in hepatocytes when acutely injured livers regenerate. To evaluate this ...
Full textLink to itemCite
Journal ArticleClin Transplant · October 2018
Human leukocyte antigen (HLA) serotyping is not considered to have significant impact on liver graft survival and does not factor into U.S. organ allocation. Immune-related liver diseases such as primary sclerosing cholangitis (PSC), autoimmune hepatitis ( ...
Full textLink to itemCite
Journal ArticleTransplant Direct · May 2018
BACKGROUND: Combined lung-liver transplantation (LLT) applies 2 technically challenging transplants in 1 patient with severe 2-organ failure. METHODS: Institutional medical records and United Network for Organ Sharing database were queried for patients at ...
Full textOpen AccessLink to itemCite
Journal ArticleOpen Forum Infect Dis · April 2018
Electronic medical record platforms fail to support provider alerts when a drug is discontinued. Protease inhibitors, often boosted by ritonavir or cobicistat, increase the serum concentration of calcineurin inhibitors. This case demonstrates acute liver t ...
Full textOpen AccessLink to itemCite
Journal ArticleGastroenterology · March 2018
BACKGROUND & AIMS: Little is known about substitutions that mediate resistance of hepatitis C virus (HCV) to direct-acting antivirals (DAAs), due to the small number of patients with treatment failure in approval studies. It is important to identify resist ...
Full textLink to itemCite
Journal ArticleLiver Transpl · December 2017
Living donor liver transplantation (LDLT) is a technically demanding endeavor, requiring command of the complex anatomy of partial liver grafts. We examined the influence of anatomic variation and reconstruction techniques on surgical outcomes and graft su ...
Full textLink to itemCite
Journal ArticleJ Magn Reson Imaging · June 2016
PURPOSE: To determine whether reader perception of a capsule affects reader interpretation of washout in hypervascular liver nodules at dynamic magnetic resonance imaging (MRI) in patients at risk for hepatocellular carcinoma (HCC). MATERIALS AND METHODS: ...
Full textLink to itemCite
Journal ArticleAm J Transplant · June 2016
The Organ Procurement and Transplantation Network (OPTN) Deceased Donor Potential Study, funded by the Health Resources and Services Administration, characterized the current pool of potential deceased donors and estimated changes through 2020. The goal wa ...
Full textLink to itemCite
Journal ArticleDig Dis Sci · May 2016
Nonalcoholic fatty liver disease (NAFLD) is the most common etiology of chronic liver disease in developed countries and is on trajectory to become the leading indication for liver transplantation in the USA and much of the world. Patients with NAFLD cirrh ...
Full textLink to itemCite
Journal ArticleCurrent Transplantation Reports · March 1, 2016
The process by which the United Network for Organ Sharing (UNOS) allocates its effort is central to the pursuit of its mission. UNOS serves to support the field of solid organ and vascularized composite allograft transplantation and donation, and its many ...
Full textCite
Journal ArticleJ Vasc Interv Radiol · January 2016
PURPOSE: To assess the effectiveness of bland transarterial embolization of hepatocellular carcinoma (HCC) as a "bridge" to transplantation. MATERIALS AND METHODS: In this retrospective study, 117 patients with HCC that met Milan criteria underwent bland e ...
Full textLink to itemCite
Journal ArticleN C Med J · 2016
Liver transplantation is a lifesaving intervention for patients with decompensated cirrhosis, certain malignancies, and genetic disorders associated with disordered liver metabolism. This commentary will discuss the indications for liver transplantation, t ...
Full textLink to itemCite
ConferenceAnn Surg · September 2015
OBJECTIVES: To compare long-term survival of living donor liver transplant (LDLT) at experienced transplant centers with outcomes of deceased donor liver transplant and identify key variables impacting patient and graft survival. BACKGROUND: The Adult-to-A ...
Full textLink to itemCite
Journal ArticleJ Magn Reson Imaging · August 2015
PURPOSE: To determine the rate of agreement between the Organ Procurement and Transplant Network (OPTN) and Liver Imaging Reporting and Data System (LI-RADS) classifications for hypervascular liver nodules at least 1 cm in diameter, and for patient eligibi ...
Full textLink to itemCite
Journal ArticleJ Hepatol · February 2015
BACKGROUND & AIMS: There are few long-term studies of the health-related quality of life (HRQOL) in living liver donors. This study aimed to characterize donor HRQOL in the Adult to Adult Living Donor Liver Transplantation Study (A2ALL) up to 11 years post ...
Full textLink to itemCite
Journal ArticleHepatology · January 2015
UNLABELLED: The Model for End-Stage Liver Disease (MELD) allocation system for liver transplantation provides "exceptions" for diseases such as hepatocellular carcinoma (HCC). It was the aim of this study to assess equipoise between exception candidates an ...
Full textLink to itemCite
Journal ArticleHepatology · April 2014
UNLABELLED: Donor factors influence hepatitis C virus (HCV) disease severity in liver transplant (LT) recipients. Living donors, because they are typically young and have short cold ischemic times, may be advantageous for HCV-infected patients. Among HCV-i ...
Full textLink to itemCite
Journal ArticleAm J Transplant · February 2014
Many transplant centers use endoscopically directed brachytherapy to provide locoregional control in patients with otherwise incurable cholangiocarcinoma (CCA) who are awaiting liver transplantation (LT). The use of endoscopic retrograde cholangiopancreato ...
Full textLink to itemCite
Journal ArticleCancer Chemother Pharmacol · December 2013
PURPOSE: N(1),N(11)-diethylnorspermine (DENSPM), a synthetic analog of the naturally occurring polyamine spermine, can induce polyamine depletion and inhibit tumor cell growth. The objectives of this phase I study were to assess the safety, maximum-tolerat ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · January 2013
BACKGROUND: During the evaluation of a needle-stick injury, an orthopedic surgeon was found to be unknowingly infected with hepatitis B virus (HBV) (viral load >17.9 million IU/mL). He had previously completed two 3-dose series of hepatitis B vaccine witho ...
Full textLink to itemCite
Journal ArticleAm J Transplant · November 2012
Hepatocellular carcinoma (HCC) represents an increasing fraction of liver transplant indications; the role of living donor liver transplant (LDLT) remains unclear. In the Adult-to-Adult Living Donor Liver Transplantation Cohort Study, patients with HCC and ...
Full textLink to itemCite
Journal ArticleLiver Transpl · June 2012
Hepatitis C virus (HCV) is a controversial indication for liver transplantation (LT) in human immunodeficiency virus (HIV)-infected patients because of reportedly poor outcomes. This prospective, multicenter US cohort study compared patient and graft survi ...
Full textLink to itemCite
Journal ArticleGastrointestinal Cancer Research · January 1, 2012
Background: Transcatheter arterial chemoembolization (TACE) improves survival in patients with unresectable hepatocellular carcinoma (HCC). Partial liver radiotherapy with modern techniques has been shown to be safe. The purpose of this study was to evalua ...
Cite
Journal ArticleAm J Transplant · November 2011
MELD (model for end-stage liver disease) exception awards affect the liver allocation process. Award rates of specific nonhepatocellular carcinoma exceptions, termed symptom-based exceptions (SBE), differ across UNOS regions. We aimed to characterize the r ...
Full textLink to itemCite
Journal ArticleHepatology · October 2011
UNLABELLED: Receipt of a living donor liver transplant (LDLT) has been associated with improved survival compared with waiting for a deceased donor liver transplant (DDLT). However, the survival benefit of liver transplant has been questioned for candidate ...
Full textLink to itemCite
Journal ArticleLiver Transpl · April 2011
Information on the long-term health of living liver donors is incomplete. Because changes in standard laboratory tests may reflect the underlying health of donors, results before and after donation were examined in the Adult-to-Adult Living Donor Liver Tra ...
Full textLink to itemCite
Journal ArticleAm J Transplant · July 2010
Data submitted by transplant programs to the Organ Procurement and Transplantation Network (OPTN) are used by the Scientific Registry of Transplant Recipients (SRTR) for policy development, performance evaluation and research. This study compared OPTN/SRTR ...
Full textLink to itemCite
Journal ArticleAm J Transplant · May 2010
Liver transplantation (LT) is the treatment of choice for end-stage liver disease, but is controversial in patients with human immunodeficiency virus (HIV) infection. Using a prospective cohort of HIV-hepatitis B virus (HBV) coinfected patients transplante ...
Full textLink to itemCite
Journal ArticleLiver Transpl · April 2010
The Model for End-Stage Liver Disease system has given priority on the liver transplant waiting list to candidates with renal failure. This study determined the predictors of spontaneous recovery of renal function after transplantation in 1041 liver transp ...
Full textLink to itemCite
Journal ArticleAnn Surg · March 2010
OBJECTIVE: To compare rates of hospitalization before and after adult-to-adult living donor liver transplant (LDLT) and deceased donor liver transplant (DDLT). SUMMARY BACKGROUND DATA: LDLT recipients have been reported to have lower mortality but a higher ...
Full textLink to itemCite
Journal ArticleCancer · November 1, 2009
BACKGROUND: : Patients with unresectable hepatocellular carcinoma (HCC) have limited treatment options. In this study, the authors investigated the feasibility, toxicity, and efficacy associated with intensity-modulated radiation therapy (IMRT) and concurr ...
Full textLink to itemCite
Journal ArticleTranspl Int · September 2009
With the implementation of the Model for End-Stage Liver Disease (MELD) scoring system, the number of combined liver-kidney transplants (CLKT) has increased dramatically. The United Network for Organ Sharing (UNOS) dataset was analysed for adult recipients ...
Full textLink to itemCite
Journal ArticleEndoscopy · September 2009
Techniques for management of bile leaks include biliary sphincterotomy and stenting. Partially covered self-expandable metallic stents have been used in complex bile leaks, but they are associated with migration and hyperplasia. A fully covered self-expand ...
Full textLink to itemCite
Journal ArticleAm J Transplant · April 2009
Liver transplantation numbers in the United States remained constant from 2004 to 2007, while the number of waiting list candidates has trended down. In 2007, the waiting list was at its smallest since 1999, with adults > or =50 years representing the majo ...
Full textLink to itemCite
Journal ArticleTechnol Cancer Res Treat · February 2009
This retrospective study was undertaken to obtain information regarding the survival and toxicities after Yttrium-90 microspheres treatment in patients with primary liver malignancies. Baseline, treatment, and follow-up data were collected and analyzed for ...
Full textLink to itemCite
Journal ArticleClin Liver Dis · February 2009
Patients who have liver disease experience an increased risk for bleeding and resulting complications. Diseases affecting the liver can cause a deficiency of pro-coagulant factors or induce a state of increased clot breakdown. Although traditional tests of ...
Full textLink to itemCite
Journal ArticleLiver Transpl · February 2009
Using outcomes data from the Adult-to-Adult Living Donor Liver Transplantation Cohort Study, we performed a cost-effectiveness analysis exploring the costs and benefits of living donor liver transplantation (LDLT). A multistage Markov decision analysis mod ...
Full textLink to itemCite
Journal ArticleAnn Hepatol · 2009
INTRODUCTION: Epidemiological studies indicate that nonalcoholic steatohepatitis (NASH) is a common cause of cirrhosis described as 'cryptogenic'. To address this from a histological perspective and to examine the significance of residual histological find ...
Link to itemCite
Journal ArticleAnn Thorac Surg · January 2009
BACKGROUND: Hepatic hydrothorax in the setting of decompensated cirrhosis is a challenging and common clinical problem. Traditional therapies such as diuretics and transjugular intrahepatic portosystemic shunts can be effective therapies in selected patien ...
Full textLink to itemCite
Journal ArticleAm J Transplant · April 2008
Liver transplantation in 2006 generally resembled previous years, with fewer candidates waiting for deceased donor liver transplants (DDLT), continuing a trend initiated with the implementation of the model for end-stage liver disease (MELD). Candidate age ...
Full textLink to itemCite
Journal ArticleClin Gastroenterol Hepatol · March 2008
BACKGROUND & AIMS: Photodynamic therapy (PDT) for unresectable cholangiocarcinoma is associated with improvement in cholestasis, quality of life, and potentially survival. We compared survival in patients with unresectable cholangiocarcinoma undergoing end ...
Full textLink to itemCite
Journal ArticleNat Clin Pract Gastroenterol Hepatol · January 2008
BACKGROUND: A 39-year-old man presented with a 2-month history of abdominal pain, jaundice, non-bloody diarrhea, weakness, and weight loss. Initial evaluation revealed intrahepatic ductopenia consistent with vanishing bile duct syndrome and IBD, type uncla ...
Full textLink to itemCite
Journal ArticleJ Thromb Haemost · January 2008
A complex balance exists between endogenous procoagulants and the anticoagulant system in liver disease patients. Hypercoagulable events occur in cirrhosis patients despite the well-known bleeding diathesis of liver disease. These events may be clinically ...
Full textLink to itemCite
Journal ArticleGastroenterology · December 2007
BACKGROUND & AIMS: More than 2000 adult-to-adult living donor liver transplantations (LDLT) have been performed in the United States, yet the potential benefit to liver transplant candidates of undergoing LDLT compared with waiting for deceased donor liver ...
Full textLink to itemCite
Journal ArticleAm J Transplant · August 2007
The use of extended criteria liver donors (ECD) is controversial, especially in the setting of retransplantation. The aims of this study are to investigate the effects of ECD grafts on retransplantation and to develop a predictive mortality index in liver ...
Full textLink to itemCite
Journal ArticleAm J Transplant · June 2007
We examined mortality and recurrence of hepatocellular carcinoma (HCC) among 106 transplant candidates with cirrhosis and HCC who had a potential living donor evaluated between January 1998 and February 2003 at the nine centers participating in the Adult-t ...
Full textLink to itemCite
Journal ArticleHepatology · October 2006
Normal coagulation has classically been conceptualized as a Y-shaped pathway, with distinct "intrinsic" and "extrinsic" components initiated by factor XII or factor VIIa/tissue factor, respectively, and converging in a "common" pathway at the level of the ...
Full textLink to itemCite
Journal ArticleAm J Transplant · October 2006
It has been demonstrated that low-volume orthotopic liver transplant centers have poorer outcomes compared to high-volume centers. In light of the recent significant changes in liver transplantation, we performed an analysis of transplant center procedure ...
Full textLink to itemCite
Journal ArticleClin Gastroenterol Hepatol · August 2006
BACKGROUND & AIMS: Wilson's disease is a genetic autosomal-recessive copper deposition disorder often presenting with neurologic or hepatic symptoms. In cases of hepatic presentation, treatment usually is initiated with potentially toxic copper chelators, ...
Full textLink to itemCite
Journal ArticleAm J Gastroenterol · July 2006
OBJECTIVE: Despite the endogenous coagulopathy of cirrhosis, some patients with cirrhosis experience thrombophilic states. This study aims to determine the incidence and predictors of venous thromboembolism (VTE), such as deep vein thrombosis (DVT) and pul ...
Full textLink to itemCite
Journal ArticleJ Viral Hepat · July 2006
We conducted a randomized multinational study to determine whether 48 weeks of re-treatment with peginterferon-alpha-2a (40 kDa) plus ribavirin would induce a sustained virological response (SVR) in relapsed chronic hepatitis C patients. Patients who had p ...
Full textLink to itemCite
Journal ArticleAm J Transplant · 2006
Measuring and monitoring performance--be it waiting list and posttransplant outcomes by a transplant center, or organ donation success by an organ procurement organization and its partnering hospitals--is an important component of ensuring good care for pe ...
Full textLink to itemCite
Journal ArticleClin Gastroenterol Hepatol · August 2005
BACKGROUND & AIMS: Esophagogastroduodenoscopy (EGD) is the current standard for evaluating esophageal varices, yet there is no universally accepted system of grading varices endoscopically and several studies have shown interobserver variability of endosco ...
Full textLink to itemCite
Journal ArticleAnn Surg · August 2005
OBJECTIVE: We sought to determine the ability of the Model for End-Stage Liver Disease (MELD) score to predict 30-day postoperative mortality for patients with cirrhosis undergoing nontransplant surgical procedures. SUMMARY BACKGROUND DATA: The Child-Pugh ...
Full textLink to itemCite
Journal ArticleHealth Policy · May 2005
Adult-to-adult living donor liver transplantation (LDLT) is in a state of flux. Technical innovations and demand have outpaced internal and external regulatory efforts. This has led to a wide array of centers performing LDLT for a variety of indications wi ...
Full textLink to itemCite
Journal ArticleJ Clin Gastroenterol · April 2005
BACKGROUND: Traditional endoscopy center scheduling often results in nonurgent inpatient endoscopic procedures being delayed until late in the day and can prolong length of hospital stay and costs. We report the first controlled study designed to evaluate ...
Full textLink to itemCite
Journal ArticleAm J Transplant · October 2004
Changes in model for end-stage liver disease (MELD) score of > or = 5 points over 30 days (delta-MELD) is an independent predictor for death in patients awaiting liver transplantation. The aim of the current study was to determine if a positive change in M ...
Full textLink to itemCite
Journal ArticleCell · September 17, 2004
FLVCR, a member of the major facilitator superfamily of transporter proteins, is the cell surface receptor for feline leukemia virus, subgroup C. Retroviral interference with FLVCR display results in a loss of erythroid progenitors (colony-forming units-er ...
Full textLink to itemCite
Journal ArticleJ Neurol Sci · September 15, 2004
We report a 46-year-old-man who developed recurrent myelitis associated with hepatitis C viral (HCV) infection. Spinal cord biopsy showed acute demyelination without evidence of vasculitis. Antibodies to HCV were present in the CSF; HCV RNA was not detecte ...
Full textLink to itemCite
Journal ArticleAm J Physiol Gastrointest Liver Physiol · June 2001
Heme is the most bioavailable form of dietary iron and a component of many cellular proteins. Controversy exists as to whether heme uptake occurs via specific transport mechanisms or passive diffusion. The aims of this study were to quantify cellular heme ...
Full textLink to itemCite
Journal ArticleHepatology · August 2000
Hepatitis C virus (HCV) allograft infection after liver transplantation follows a variable but accelerated course compared with the nontransplantation population. Predictors of outcome and mechanisms of reinfection remain elusive. The accelerated HCV-induc ...
Full textLink to itemCite
Journal ArticleAm J Gastroenterol · December 1999
We describe a case of prolonged cholestasis temporally associated with the use of itraconazole for onychomycosis. Peak bilirubin level of 32.0 mg/dl was documented approximately 2 months after discontinuation of the patient's itraconazole therapy, with sym ...
Full textLink to itemCite
Journal ArticleAm J Physiol · October 1998
Gluconeogenesis and glycogenolysis are essential hepatic functions required for glucose homeostasis. During the initial phase of hepatic regeneration, the immediate-early genes (IEG) are rapidly expressed, and the IEG RL-1 encodes for glucose-6-phosphatase ...
Full textLink to itemCite
Journal ArticleAm J Gastroenterol · June 1997
We report the case of a 68-yr-old woman who had previously undergone a total colectomy and ileostomy for Crohn's disease limited to the colon. She subsequently had recurrent episodes of severe stomal bleeding and was discovered to have micronodular cirrhos ...
Link to itemCite
Journal ArticleHepatology · November 1996
Significant controversy exists regarding the regulation of glucuronidation during the process of hepatic regeneration. We used a partial hepatectomy rat model to elucidate the effects of hepatic regeneration on the various components of the microsomal gluc ...
Full textLink to itemCite
Journal ArticleBiochim Biophys Acta · September 4, 1996
Previous studies have documented the presence of protein-mediated transport of UDP-glucuronic acid (UDP-GlcUA) in rat liver endoplasmic reticulum (ER). Measurement of uptake at varying concentrations of high specific activity [beta-32P]UDP-GlcUA has reveal ...
Full textLink to itemCite
Journal ArticleClinical Immunotherapeutics · January 1, 1996
Primary biliary cirrhosis is a well-characterised disorder of autoimmune origin whose exact pathogenesis remains poorly understood. Population studies have suggested an association with human leucocyte antigen (HLA)-DRS, and patients are universally positi ...
Full textCite
Journal ArticleAm J Physiol · October 1995
Non-transferrin-bound iron (NTBI) plays an important role in the hepatocellular injury induced by iron overload. However, the mechanism responsible for NTBI uptake into hepatocytes remains poorly defined. The purpose of this study was to define the kinetic ...
Full textLink to itemCite
Journal ArticleGastroenterology · January 1995
BACKGROUND/AIMS: Hepatic glucuronidation is quantitatively the most important conjugation reaction by which an array of endogenous compounds and xenobiotics undergo biotransformation and detoxification. The active site of the uridine diphosphate (UDP) gluc ...
Full textLink to itemCite
Journal ArticleBiochim Biophys Acta · October 12, 1994
The endoplasmic reticulum (ER) of rat liver contains several well characterized UDP-glucuronosyltransferases (UGTs), membrane-bound proteins of 50-54 kDa, and also less well identified UDP-glucosyltransferases, with nucleotide binding sites located on the ...
Full textLink to itemCite
Journal ArticleScand J Gastroenterol Suppl · 1992
The immunologic mechanisms responsible for the development of primary biliary cirrhosis (PBC) remain poorly defined, although recent investigations have provided new clues as to the role of cellular membrane proteins such as the mitochondrial autoantigens ...
Full textLink to itemCite
Journal ArticleMed Clin North Am · July 1991
As clinical experience with patients with ZES has grown, increasing recognition has been made of the broad spectrum of symptoms associated with gastrinomas. Diarrhea and acid-induced esophageal injury have taken their place alongside chronic peptic ulcer d ...
Full textLink to itemCite
Journal ArticleEndoscopy · July 1991
A 60-year-old male presented with findings on radiographic and physical examination which were compatible with colonic obstruction. A tube cecostomy was performed. Colonoscopy seven months later revealed a pseudotumor composed of granulation tissue in the ...
Full textLink to itemCite
Journal ArticleCurrent Opinion in Gastroenterology · January 1, 1991
Diseases that fall into the category of metabolic liver diseases are generally considered to include disorders of hepatic synthesis and degradation or regulation of a diverse variety of endogenous compounds. The spectrum of abnormalities ranges from disord ...
Full textCite